These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22967709)

  • 1. 1α,25-dihydroxyvitamin D3 and rosiglitazone synergistically enhance osteoblast-mediated mineralization.
    Woeckel VJ; Bruedigam C; Koedam M; Chiba H; van der Eerden BC; van Leeuwen JP
    Gene; 2013 Jan; 512(2):438-43. PubMed ID: 22967709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of vitamin D and interferon-β cross-talk in human osteoblasts with 1α,25-dihydroxyvitamin D3 being dominant over interferon-β in stimulating mineralization.
    Woeckel VJ; Koedam M; van de Peppel J; Chiba H; van der Eerden BC; van Leeuwen JP
    J Cell Physiol; 2012 Sep; 227(9):3258-66. PubMed ID: 22105341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1α,25-dihydroxyvitamin D3 stimulates activin A production to fine-tune osteoblast-induced mineralization.
    Woeckel VJ; van der Eerden BC; Schreuders-Koedam M; Eijken M; Van Leeuwen JP
    J Cell Physiol; 2013 Nov; 228(11):2167-74. PubMed ID: 23589129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1Alpha,25-(OH)2D3 acts in the early phase of osteoblast differentiation to enhance mineralization via accelerated production of mature matrix vesicles.
    Woeckel VJ; Alves RD; Swagemakers SM; Eijken M; Chiba H; van der Eerden BC; van Leeuwen JP
    J Cell Physiol; 2010 Nov; 225(2):593-600. PubMed ID: 20506116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
    van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
    J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DKK1 Induced by 1,25D3 Is Required for the Mineralization of Osteoblasts.
    Jo S; Yoon S; Lee SY; Kim SY; Park H; Han J; Choi SH; Han JS; Yang JH; Kim TH
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
    Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
    Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
    Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
    J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl donor deficiency impairs bone development via peroxisome proliferator-activated receptor-γ coactivator-1α-dependent vitamin D receptor pathway.
    Feigerlova E; Demarquet L; Melhem H; Ghemrawi R; Battaglia-Hsu SF; Ewu E; Alberto JM; Helle D; Weryha G; Guéant JL
    FASEB J; 2016 Oct; 30(10):3598-3612. PubMed ID: 27435264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR agonists stimulate adipogenesis at the expense of osteoblast differentiation while inhibiting osteoclast formation and activity.
    Patel JJ; Butters OR; Arnett TR
    Cell Biochem Funct; 2014 Jun; 32(4):368-77. PubMed ID: 24615887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation.
    Ali AA; Weinstein RS; Stewart SA; Parfitt AM; Manolagas SC; Jilka RL
    Endocrinology; 2005 Mar; 146(3):1226-35. PubMed ID: 15591153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D control of osteoblast function and bone extracellular matrix mineralization.
    van Leeuwen JP; van Driel M; van den Bemd GJ; Pols HA
    Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):199-226. PubMed ID: 11693961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat.
    Lazarenko OP; Rzonca SO; Suva LJ; Lecka-Czernik B
    Bone; 2006 Jan; 38(1):74-84. PubMed ID: 16137931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
    Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
    J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D Signaling Modulators in Cancer Therapy.
    Luo W; Johnson CS; Trump DL
    Vitam Horm; 2016; 100():433-72. PubMed ID: 26827962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Osteoporosis-Inducing Drugs on Vitamin D-Related Gene Transcription and Mineralization in MG-63 and Saos-2 Cells.
    Wegler C; Wikvall K; Norlin M
    Basic Clin Pharmacol Toxicol; 2016 Nov; 119(5):436-442. PubMed ID: 27098343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of PPAR-γ inhibits differentiation of rat osteoblasts by reducing expression of connective tissue growth factor.
    Yu WW; Xia Q; Wu Y; Bu QY
    J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):652-656. PubMed ID: 25318873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrical responses to 1alpha,25(OH)2-Vitamin D3 and their physiological significance in osteoblasts.
    Zanello LP; Norman AW
    Steroids; 2004 Aug; 69(8-9):561-5. PubMed ID: 15288770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.